Particle.news

Download on the App Store

Rush University Pauses Hormonal Care for New Transgender Minors

Effective July 1, federal funding threats prompted Rush to stop hormonal treatments for new transgender minors.

Rush University Medical Center on Sept. 13, 2022. (Antonio Perez/Chicago Tribune)
Image

Overview

  • Rush University Medical Center paused puberty blockers and hormone replacement therapy for new patients under 18 starting July 1.
  • Existing minor patients may continue treatments only if halting care would risk harm to their health.
  • The hospital will still offer mental health, behavioral health and social services to all gender care patients and full medical gender-affirming services to adults.
  • Rush’s decision follows President Trump’s January executive order threatening to withdraw federal research grants and Medicare and Medicaid reimbursements.
  • Similar suspensions at Lurie Children’s and UI Health reflect a broader trend as providers respond to federal enforcement and DOJ subpoenas of patient records.